Cargando…

Evaluation of ADAM-12 as a Diagnostic Biomarker of Ectopic Pregnancy in Women with a Pregnancy of Unknown Location

BACKGROUND: Ectopic pregnancy (EP) remains the most life-threatening acute condition in modern gynaecology. It remains difficult to diagnose early and accurately. Women often present at emergency departments in early pregnancy with a ‘pregnancy of unknown location’ (PUL) and diagnosis/exclusion of E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horne, Andrew W., Brown, Jeremy K., Tong, Stephen, Kaitu'u-Lino, Tu'uhevaha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424157/ https://www.ncbi.nlm.nih.gov/pubmed/22927907 http://dx.doi.org/10.1371/journal.pone.0041442

Ejemplares similares

Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location
por: Skubisz, Monika M., et al.
Publicado: (2013)

Measuring circulating miRNAs in early pregnancy could identify fetuses’ destined to undergrow and be at increased risk of stillbirth
por: Tong, Stephen, et al.
Publicado: (2020)

Therapeutic interventions: The importance of including diseased and healthy samples in preclinical studies
por: Tu'uhevaha J., Kaitu'u-Lino
Publicado: (2019)

Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy
por: Hastie, Roxanne, et al.
Publicado: (2018)

Serum Concentrations of Soluble Flt-1 Are Decreased among Women with a Viable Fetus and No Symptoms of Miscarriage Destined for Pregnancy Loss
por: Kaitu'u-Lino, Tu'uhevaha J., et al.
Publicado: (2012)

Plasma MIC-1 and PAPP-A Levels Are Decreased among Women Presenting to an Early Pregnancy Assessment Unit, Have Fetal Viability Confirmed but Later Miscarry
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2013)

A comparison of sample collection methods for quantifying cell-free fetal neurodevelopment transcripts in amniotic fluid
por: Hui, Lisa, et al.
Publicado: (2016)

MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2012)

The Regulation of Endothelin-1 in Pregnancies Complicated by Gestational Diabetes: Uncovering the Vascular Effects of Insulin
por: Fato, Bianca R., et al.
Publicado: (2023)

A Bioplex Analysis of Cytokines and Chemokines in First Trimester Maternal Plasma to Screen for Predictors of Miscarriage
por: Hannan, Natalie J., et al.
Publicado: (2014)

Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries—A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development
por: Fato, Bianca R., et al.
Publicado: (2022)

Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta
por: Brownfoot, Fiona C., et al.
Publicado: (2016)

Clinical tools and biomarkers to predict preeclampsia
por: MacDonald, Teresa M, et al.
Publicado: (2021)

Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia
por: Hannan, Natalie J., et al.
Publicado: (2018)

ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia
por: Pritchard, Natasha, et al.
Publicado: (2018)

Plasma lipids are dysregulated preceding diagnosis of preeclampsia or delivery of a growth restricted infant
por: Bartho, Lucy A., et al.
Publicado: (2023)

Placental Growth Factor Is Secreted by the Human Endometrium and Has Potential Important Functions during Embryo Development and Implantation
por: Binder, Natalie K., et al.
Publicado: (2016)

A double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial): study protocol
por: Cluver, Catherine, et al.
Publicado: (2019)

PSG7 and 9 (Pregnancy‐Specific β‐1 Glycoproteins 7 and 9): Novel Biomarkers for Preeclampsia
por: Kandel, Manju, et al.
Publicado: (2022)

Pre-Clinical Investigation of Cardioprotective Beta-Blockers as a Therapeutic Strategy for Preeclampsia
por: Binder, Natalie K., et al.
Publicado: (2021)

Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease
por: de Alwis, Natasha, et al.
Publicado: (2022)

Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia
por: Binder, Natalie K., et al.
Publicado: (2023)

DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia
por: de Alwis, Natasha, et al.
Publicado: (2021)

Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction – implications for treating preeclampsia
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2018)

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
por: Hannan, Natalie J., et al.
Publicado: (2017)

Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction
por: Brownfoot, Fiona C., et al.
Publicado: (2019)

Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth
por: Arman, Bridget M., et al.
Publicado: (2023)

Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
por: Hastie, Roxanne, et al.
Publicado: (2022)

Placental galectin-3 is reduced in early-onset preeclampsia
por: Kandel, Manju, et al.
Publicado: (2022)

Pregnancy of unknown location
por: Pereira, Pedro Paulo, et al.
Publicado: (2019)

Measuring thyroid peroxidase antibodies on the day nulliparous women present for management of miscarriage: a descriptive cohort study
por: Grossmann, Mathis, et al.
Publicado: (2013)

Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial
por: Cluver, Catherine A, et al.
Publicado: (2021)

Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth
por: Hannan, Natalie J., et al.
Publicado: (2020)

Circulating GATA2 mRNA is decreased among women destined to develop preeclampsia and may be of endothelial origin
por: Whigham, Carole-Anne, et al.
Publicado: (2019)

Comparison of the diagnostic values of circulating steroid hormones, VEGF-A, PIGF, and ADAM12 in women with ectopic pregnancy
por: Zou, Shien, et al.
Publicado: (2013)

MicroRNAs 363 and 149 are differentially expressed in the maternal circulation preceding a diagnosis of preeclampsia
por: Whigham, Carole-Anne, et al.
Publicado: (2020)

Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2020)

Diagnostic value of a urine test in pregnancy of unknown location
por: Schmitt, Andy, et al.
Publicado: (2023)

Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks’ gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study
por: MacDonald, Teresa M., et al.
Publicado: (2018)

Circulating SPINT1 Is Reduced in a Preeclamptic Cohort with Co-Existing Fetal Growth Restriction
por: Murphy, Ciara N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ic0tmevhc3894fp12bhck0icqr